This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., Beth Israel Deaconess Medical Center, Inc.. Active years: 2026.
Company Filing History:
2 out of 1,264 
1 out of 536 
Years Active: 2026
Title: Inchul You: Innovator in Cancer Therapeutics
Introduction
Inchul You is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of cancer therapeutics through his innovative research and development efforts. His work focuses on creating novel compounds that can effectively target and degrade specific proteins involved in cancer and inflammatory diseases.
Latest Patents
Inchul You holds 1 patent for his invention titled "ERK5 degraders as therapeutics in cancer and inflammatory diseases." This patent discloses bispecific compounds, known as degraders, that specifically target ERK5 for degradation. The patent also includes pharmaceutical compositions containing these degraders and outlines methods for using the compounds to treat cancer and inflammatory diseases.
Career Highlights
Inchul You is affiliated with the Dana-Farber Cancer Institute Inc., where he conducts his research. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from various forms of cancer and inflammatory conditions.
Collaborations
Inchul You collaborates with esteemed colleagues, including Jie Jiang and Fleur M. Ferguson. These partnerships enhance the research efforts and contribute to the advancement of therapeutic strategies in oncology.
Conclusion
Inchul You's innovative work in developing ERK5 degraders represents a significant advancement in cancer therapeutics. His contributions have the potential to improve treatment outcomes for patients facing challenging health conditions.